Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tara Gholamian

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Pediatrics|March 19, 2024
Morquio B disease: a case reportTara Gholamian, Harpreet Chhina, Sylvia Stockler, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2023
Suprachoroidal Injection: A Novel Approach for Targeted Drug DeliveryKevin Y Wu, Jamie K Fujioka, Tara Gholamian, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|September 9, 2024
Attitudes of Canadian ophthalmology residents on rural and Indigenous ophthalmology educationHamza Inayat, Tara Gholamian, Jillian Bertrand, et al.
Ophthalmology. Retina|November 6, 2025
Comparative Analysis of Ocular Adverse Events between Aflibercept 8 mg and Faricimab: A Global Population-Based Study across 65 CountriesMoiz Lakhani, Marko M Popovic, Abdullah Al-Ani, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Pediatrics|March 19, 2024
Morquio B disease: a case reportTara Gholamian, Harpreet Chhina, Sylvia Stockler, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2023
Suprachoroidal Injection: A Novel Approach for Targeted Drug DeliveryKevin Y Wu, Jamie K Fujioka, Tara Gholamian, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|September 9, 2024
Attitudes of Canadian ophthalmology residents on rural and Indigenous ophthalmology educationHamza Inayat, Tara Gholamian, Jillian Bertrand, et al.
Ophthalmology. Retina|November 6, 2025
Comparative Analysis of Ocular Adverse Events between Aflibercept 8 mg and Faricimab: A Global Population-Based Study across 65 CountriesMoiz Lakhani, Marko M Popovic, Abdullah Al-Ani, et al.
Pageof 1